Life360, Inc. — Director's Dealing 2019

Aug 20, 2019

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Life360, Inc.

ARBN: 629 412 942

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	James Synge
Date of last notice	19/07/2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct Interest
Nature of indirect interest	N/A
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change	14/08/2019 (PDT) / 15/08/2019 (AEST)
No. of securities held prior to change	480,347 shares of common stock (Shares)
	(equivalent to 1,441,041 Chess Depositary
	Interests (CDIs))
	6,250 Restricted Stock Units (RSUs)
	64,379 Shares (equivalent to 193,137 CDIs)
	held byICCA Labs,LLC1
Class	RSUs in Shares
Number acquired	1,562 Shares (equivalent to 4,686 CDIs)
Number disposed	Nil

1 Carthona Capital FS Pty Ltd (an affiliate of James Synge) is a member of ICCA Labs, LLC, an entity that holds Life360, Inc. shares. The number of shares attributable to James Synge by reason of his membership of ICCA Labs, LLC is 64,379

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	RSUs are granted and vest for noconsideration.
No. of securities held after change	481,909 Shares (equivalent to 1,445,727CDIs)4,688 RSUs64,379 Shares (equivalent to 193,137 CDIs)held by ICCA Labs, LLC
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back	Vesting of RSUs

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	Securities were issued pursuantto vesting of RSUs under theCompany’s Stock Incentive Planwhich arose during a closedperiod – there was no trade perse.
If so, was prior written clearance provided to allow the tradeto proceed during this period?	N/A – transaction arises out ofparticipationintheStockIncentive Plan, which is exemptfrom the Trading policy
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3